Peptide BPC 157
BPC-157 is a synthetic peptide promoted online for tendon, ligament, muscle, gastrointestinal and postoperative healing. It is not an FDA-approved human drug.
Search treatments, providers, wellness resources and patient education.
BPC-157 is a synthetic peptide promoted online for tendon, ligament, muscle, gastrointestinal and postoperative healing. It is not an FDA-approved human drug.

Retatrutide is an investigational triple receptor agonist targeting GIP, GLP-1 and glucagon receptors. Multiple Phase 3 studies have reported positive topline results, but FDA has not approved it for any condition.